SSE Ticker: 600750

Jiangzhong Pharmaceutical Co., Ltd.

江中药业

Authorized Representative: 卢小青

Board: Main A

Industry Classification: Manufacturing

[The most complete] Comprehensive comparison of listed companies in the proprietary Chinese medicine industry in North China in 2021__中国医疗

Post date September 15, 2021 — 13:46 Post Lock

East China traditional Chinese medicine companies’ mid-year report: Kang Enbei, ST medicinal revenue, and net profit both fell by more than 60%. Enterprises invested less than 30 million in research and development-Stock Channel-Hexun.com

Post date September 3, 2021 — 15:50 Post Lock

Jiangzhong Pharmaceutical: The company has completed the repurchase and has repurchased approximately 6.3 million shares in total, accounting for 1%

Post date August 31, 2021 — 01:50 Post Lock

[The most complete] Comprehensive comparison of listed companies in the Chinese patent medicine industry in Northwest China in 2021 (with business layout summary, performance comparison, business planning, etc.)

Post date August 29, 2021 — 15:03 Post Lock

collect! Interpretation of investment and financing data in China's consumer segment from January to July 2021 (1) Health food is a hot investment area

Post date August 25, 2021 — 12:55 Post Lock

Jiangzhong Pharmaceutical (600750.SH) has repurchased a total of 850,000 shares at a cost of 9,790,700 yuan_stock information_market_china gold online

Post date August 1, 2021 — 17:27 Post Lock

Jiangzhong Pharmaceutical (600750.SH) has repurchased a total of 850,000 shares at a cost of 9,790,700 yuan

Post date August 1, 2021 — 17:11 Post Lock

Jiangzhong Pharmaceutical: Jiangzhong Pharmaceutical's progress on share repurchase-CFi.CN 中财网

Post date August 1, 2021 — 17:06 Post Lock

Jiangzhong Pharmaceutical: Accumulatively repurchased 850,000 shares, accounting for 0.13%

Post date August 1, 2021 — 16:55 Post Lock

Jiangzhong Pharmaceutical: Accumulatively repurchased 850,000 shares, accounting for 0.13%

Post date August 1, 2021 — 16:53 Post Lock

The Chinese medicine sector fell across the board, Guangyu Yuan stopped falling, and Pien Tze Huang fell more than 8%_stock information_market_china gold online

Post date July 22, 2021 — 11:04 Post Lock

[Transfer stocks] Liquor sector rose, Guang Yuyuan (600771.CN) rose 10.01%-Hong Kong stocks-Financial sector

Post date July 14, 2021 — 12:44 Post Lock

Looking through the top 20 bull and bear stocks in a week: the best stocks have 3 boards in 4 days, can lithium batteries catch up? -Stock Channel-Hexun.com

Post date July 12, 2021 — 01:36 Post Lock

China Resources Pharmaceutical's 2.3 billion entry into Boya Biology is approved to increase the blood products field to complement the big health sector_International Market_Market_中金在线

Post date July 9, 2021 — 10:52 Post Lock

Chinese medicine concept stocks weakened in early trading, Jiangzhong Pharmaceutical shares fell 9.97%

Post date July 5, 2021 — 12:55 Post Lock

Didi's "rival stock" daily limit! Lithium battery stocks are completely crazy, 180 billion white horse daily limit-stock-financial

Post date July 5, 2021 — 12:53 Post Lock

Repayment of the increased part of the financing plate profitable-stock-financial

Post date July 5, 2021 — 12:27 Post Lock

Ocean Shipping Soars COSCO Shipping Special Daily Limit-CFi.CN 中财网

Post date July 5, 2021 — 10:15 Post Lock

Live: 09:45 Jiangzhong Pharmaceutical closes down limit-CFi.CN 中财网

Post date July 5, 2021 — 10:14 Post Lock

On July 2nd 36 stocks financing net purchase of more than 50 million yuan

Post date July 5, 2021 — 10:12 Post Lock